SCHEMBL30455337

SCHEMBL30455337

CC(Nc1cccc2c1[nH]c1ccc(Br)cc12)c1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 1/20 0.51
RXFP1 Q9HBX9 1/20 0.49
CYP2D6 P10635 1/20 0.47
KCNH2 Q12809 1/20 0.47
EGFR P00533 6/20 0.45
ALOX5 P09917 1/20 0.40
PIM3 Q86V86 1/20 0.40
CCNB2 O95067 1/20 0.40
CCNE2 O96020 1/20 0.40
CDK1 P06493 1/20 0.40
CDK4 P11802 1/20 0.40
CCNB1 P14635 1/20 0.40
CCND1 P24385 1/20 0.40
CCNE1 P24864 1/20 0.40
CDK2 P24941 1/20 0.40
CCNB3 Q8WWL7 1/20 0.40
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
GABRP O00591 1/20 0.39
GABRD O14764 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25255550 1.00 AR (0.51) ARRXFP1CYP2D6KCNH2EGFR
SCHEMBL25254249 0.85 EGFR (0.56) EGFRALOX5MEN1KMT2A
SCHEMBL25291036 0.85 EGFR (0.56) EGFRALOX5MEN1KMT2A
SCHEMBL25247394 0.73 KDM4E (0.44) RXFP1EGFRPIM3MEN1KMT2A
SCHEMBL30456197 0.73 KDM4E (0.44) RXFP1EGFRPIM3MEN1KMT2A
SCHEMBL30455490 0.73 CLK4 (0.51) EGFRPIM3MEN1KMT2APLA2G7
SCHEMBL25253418 0.73 TARS1 (0.42) EGFRMEN1KMT2APLA2G7
SCHEMBL25246903 0.73 CLK4 (0.51) EGFRPIM3MEN1KMT2APLA2G7
SCHEMBL25248465 0.72 PARP11 (0.53) EGFR
SCHEMBL25245298 0.72 PARP10 (0.42) EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023121238-A1 SUBSTITUTED HETEROCYCLIC DERIVATIVE COMPOUND AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING SAME (주)메디픽 2023-06-29 WO disclosed